Burning rock publishes 2023 annual report on form 20-f

Guangzhou, china, april 29, 2024 (globe newswire) -- burning rock biotech limited (nasdaq: bnr and lse: bnr, the “company” or “burning rock”), a company focused on the application of next generation sequencing technology in the field of precision oncology, announces that on april 29, 2024 it filed its annual report on form 20-f for the year ended december 31, 2023 (the “form 20-f”) with the u.s. securities and exchange commission (“sec”). the form 20-f is available for viewing on the sec website at www.sec.gov and also on the company's website at http://ir.brbiotech.com.
BNR Ratings Summary
BNR Quant Ranking